FIM study

2018-01-07 01:23

We have succesfully finished our first First in Man study with psychoactive, anti-depressive substance, which is expected to be a breakthrough in depression treatment.

The study is conducted for one of the most promising Polish phramaceutical companies, as a part of NCBiR programme.

Go back

News

2022-02-24 19:30

Completion of a single-center phase I study of the safety and pharmacokinetics of CPL207280

We have just completed a phase I study of safety and pharmacokinetics (part B) of an innovative therapy that could be used...

2022-02-18 13:58

GcLP quality certificate for laboratory procedures

The BRG Clinical Site received the GcLP quality certificate for laboratory procedures and is in the process of obtaining GMP certification for pharmaceutical procedures.

2022-02-15 19:29

Study for healthy people with a drug against Covid-19

In BRG we are currently performing a study for healthy people with a drug against Covid-19 .
In the project we are comparing experimental injectable drug called...

2021-12-24 11:53

Phase I study finished

Our site has just succesfully finished clinical stage of phase I (two parts) study with JAK kinase inhibitors.

Safety and Pharmacokinetics of JAK/ROCK Inhibitor in Healthy Volunteers

In BRG we are just starting Study for Healthy People with an Immune Drug - Part B. The aim of the following clinical trial...

Page 3 of 10